A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor

Clinical trial NCT04078295 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04078295
Sponsor: Eisai Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Neoplasms

Start date: 2019-09-05
Primary completion: 2027-03-31
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.